Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

219 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Management of Parkinson's disease a review of current and new therapies.
Mendis T, Suchowersky O, Lang A, Gauthier S. Mendis T, et al. Among authors: suchowersky o. Can J Neurol Sci. 1999 May;26(2):89-103. Can J Neurol Sci. 1999. PMID: 10352867 Review.
The genetics of Parkinson disease: to test or not to test.
Suchowersky O. Suchowersky O. Can J Neurol Sci. 2007 Aug;34(3):266-7. doi: 10.1017/s0317167100006661. Can J Neurol Sci. 2007. PMID: 17803021 No abstract available.
Treatment of Parkinson's disease--where do we go from here?
Suchowersky O. Suchowersky O. Nat Clin Pract Neurol. 2006 Sep;2(9):461. doi: 10.1038/ncpneuro0290. Nat Clin Pract Neurol. 2006. PMID: 16932605 No abstract available.
Gambling and Parkinson disease.
Lu C, Bharmal A, Suchowersky O. Lu C, et al. Among authors: suchowersky o. Arch Neurol. 2006 Feb;63(2):298. doi: 10.1001/archneur.63.2.298-a. Arch Neurol. 2006. PMID: 16476827 No abstract available.
Initiating therapy in Parkinson's disease.
Weiner W, Ahlskog E, Factor S, Suchowersky O, Reich S. Weiner W, et al. Among authors: suchowersky o. Ann Neurol. 2009 Apr;65(4):480-1; author reply 481. doi: 10.1002/ana.21667. Ann Neurol. 2009. PMID: 19399873 No abstract available.
Parkinson's disease management: towards a new paradigm.
Guttman M, Suchowersky O. Guttman M, et al. Among authors: suchowersky o. Can J Neurol Sci. 1999 Aug;26 Suppl 2:S53-7. doi: 10.1017/s031716710000010x. Can J Neurol Sci. 1999. PMID: 10451761 Review.
Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology.
Miyasaki JM, Martin W, Suchowersky O, Weiner WJ, Lang AE. Miyasaki JM, et al. Among authors: suchowersky o. Neurology. 2002 Jan 8;58(1):11-7. doi: 10.1212/wnl.58.1.11. Neurology. 2002. PMID: 11781398
The relationship between COMT genotype and the clinical effectiveness of tolcapone, a COMT inhibitor, in patients with Parkinson's disease.
Chong DJ, Suchowersky O, Szumlanski C, Weinshilboum RM, Brant R, Campbell NR. Chong DJ, et al. Among authors: suchowersky o. Clin Neuropharmacol. 2000 May-Jun;23(3):143-8. doi: 10.1097/00002826-200005000-00003. Clin Neuropharmacol. 2000. PMID: 10895397 Clinical Trial.
Patients with Parkinson's Disease (PD) have a variable response to tolcapone, a catechol-O-methyltransferase (COMT) inhibitor. ...
Patients with Parkinson's Disease (PD) have a variable response to tolcapone, a catechol-O-methyltransferase (COMT) inhibitor. ...
Canadian Guidelines on Parkinson's Disease.
Grimes D, Gordon J, Snelgrove B, Lim-Carter I, Fon E, Martin W, Wieler M, Suchowersky O, Rajput A, Lafontaine AL, Stoessl J, Moro E, Schoffer K, Miyasaki J, Hobson D, Mahmoudi M, Fox S, Postuma R, Kumar H, Jog M; Canadian Nourological Sciences Federation. Grimes D, et al. Among authors: suchowersky o. Can J Neurol Sci. 2012 Jul;39(4 Suppl 4):S1-30. doi: 10.1017/s031716710001516x. Can J Neurol Sci. 2012. PMID: 23126020 No abstract available.
Progress in clinical neurosciences: a forum on the early management of Parkinson's disease.
Lang AE, Miyasaki J, Olanow CW, Stoessl AJ, Suchowersky O. Lang AE, et al. Among authors: suchowersky o. Can J Neurol Sci. 2005 Aug;32(3):277-86. doi: 10.1017/s0317167100004145. Can J Neurol Sci. 2005. PMID: 16225167 Review.
219 results
Jump to page
Feedback